Clearside Biomedical
CLSD
CLSD
52 hedge funds and large institutions have $43.8M invested in Clearside Biomedical in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 18 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
12% more capital invested
Capital invested by funds: $39.1M → $43.8M (+$4.74M)
1.39% more ownership
Funds ownership: 29.5% → 30.89% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
52
Holding in Top 10
1
Calls
$556K
Puts
$437K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$1.42M | |
| 3 | +$899K | |
| 4 |
Morgan Stanley
New York
|
+$875K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$825K |
Top Sellers
| 1 | -$252K | |
| 2 | -$182K | |
| 3 | -$164K | |
| 4 |
TFS
TrustCore Financial Services
Brentwood,
Tennessee
|
-$74K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$36.8K |